Quthero is a private company advancing regenerative therapies based on its proprietary Q-peptide technology for applications in dermatology and cardiology. Q-peptide is a synthetic, bioactive, peptide sequence derived from Angiopoietin-1, with documented regenerative and anti-inflammatory properties.
Q-peptide platform enables versatile applications in areas where cell survival, anti-inflammatory effects, and regenerative support are critical. Quthero’s pipeline focuses on applications of post-aesthetic procedures, wound healing and regeneration, and cardiovascular health.
Intellectual Property
Fundraising
In Market
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.
